FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ascent Pharmaceuticals Hydrocodone Bitartrate and Acetaminophen Recall

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx…

Ascent Pharmaceuticals, Inc. · Central Islip, NY

Risk level
Class II
Reported by FDA
Nov 25, 2020
Recall ID
D-0097-2021
Check your lot numberHow we source this data

Summary

Ascent Pharmaceuticals recalled Hydrocodone Bitartrate and Acetaminophen starting Oct 26, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0097-2021 on Nov 25, 2020. Reason: Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg. Status: Terminated.

Why it was recalled

Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.

Product description

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc. Central Islip, NY 11722, NDC 31722-943-01

Lot numbers, UPCs & expiration codes

Lot #: 20070518, Exp. Date June 2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0097-2021
Classification
Class II
Status
Terminated
Recall initiated
Oct 26, 2020
FDA report date
Nov 25, 2020
Quantity
9768 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascent Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0097-2021, exactly as published.

Show all FDA fields
City
Central Islip
State
NY
Status
Terminated
Country
United States
Event ID
86665
Address
400 S Technology Dr
Code information
Lot #: 20070518, Exp. Date June 2022
Postal code
11722-4402
Report date
Nov 25, 2020
Product type
Drugs
Recall number
D-0097-2021
Classification
Class II
Recalling firm
Ascent Pharmaceuticals, Inc.
Product quantity
9768 Bottles
Termination date
Feb 17, 2023
Reason for recall
Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc. Central Islip, NY 11722, NDC 31722-943-01
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 26, 2020
Initial firm notification
Letter
Center classification date
Nov 17, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0097-2021, published Nov 25, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls